Design and optimization of surfactant-based nanovesicles for ocular delivery of Clotrimazole

References

• Abdel-Moety EM, Khattab FI, Kelani KM, AbouAl-Alamein AM. (2002). Chromatographic determination of clotrimazole, ketoconazole and fluconazole in pharmaceutical formulations. Farmaco 57:931–8
   PubMedGoogle Scholar
• Baillie AJ, Coombs GH, Dolan TF, Laurie J. (1986). Non-ionic surfactant vesicles, niosomes, as a delivery system for the anti-leishmanial drug, sodium stibogluconate. J Pharm Pharmacol 38:502–5
   PubMed Web of Science ®Google Scholar
• Basalious EB, Shawky N, Badr-Eldin SM. (2010). SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: development and optimization. Int J Pharm 391:203–11
   PubMed Web of Science ®Google Scholar
• Bourlais CL, Acar L, Zia H, et al. (1998). Ophthalmic drug delivery systems – recent advances. Prog Retin Eye Res 17:33–58
   PubMed Web of Science ®Google Scholar
• Calvo P, Alonso MJ, Vila-Jato JL, Robinson JR. (1996). Improved ocular bioavailability of indomethacin by novel ocular drug carriers. J Pharm Pharmacol 48:1147–52
   PubMed Web of Science ®Google Scholar
• Ch'ng HS, Park H, Kelly P, Robinson JR. (1985). Bioadhesive polymers as platforms for oral controlled drug delivery II: synthesis and evaluation of some swelling, water-insoluble bioadhesive polymers. J Pharm Sci 74:399–405
   PubMed Web of Science ®Google Scholar
• Di Colo G, Burgalassi S, Chetoni P, et al. (2001). Gel-forming erodible inserts for ocular controlled delivery of ofloxacin. Int J Pharm 215:101–11
   PubMed Web of Science ®Google Scholar
• Duangjit S, Opanasopit P, Rojanarata T, Ngawhirunpat T. (2011). Characterization and in vitro skin permeation of meloxicam-loaded liposomes versus transfersomes. J Drug Deliv 2011: Article ID 418316, 9pp. doi: 10.1155/2011/418316
   PubMedGoogle Scholar
• El Maghraby GM, Williams AC, Barry BW. (2000). Skin delivery of oestradiol from lipid vesicles: importance of liposome structure. Int J Pharm 204:159–69
   PubMed Web of Science ®Google Scholar
• El Zaafarany GM, Awad GA, Holayel SM, Mortada ND. (2010). Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. Int J Pharm 397:164–72
   PubMed Web of Science ®Google Scholar
• Essa EA, Bonner MC, Barry BW. (2002). Iontophoretic estradiol skin delivery and tritium exchange in ultradeformable liposomes. Int J Pharm 240:55–66
   PubMed Web of Science ®Google Scholar
• Gonzalez-Mira E, Egea MA, Garcia ML, Souto EB. (2010). Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC. Colloids Surf B Biointerfaces 81:412–21
   PubMed Web of Science ®Google Scholar
• Hou D, Xie C, Huang K, Zhu C. (2003). The production and characteristics of solid lipid nanoparticles (SLNs). Biomaterials 24:1781–5
   PubMed Web of Science ®Google Scholar
• Huang YB, Tsai MJ, Wu PC, et al. (2011). Elastic liposomes as carriers for oral delivery and the brain distribution of (+)-catechin. J Drug Target 19:709–18
   PubMed Web of Science ®Google Scholar
• Jain S, Jain P, Umamaheshwari RB, Jain NK. (2003). Transfersomes – a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation. Drug Dev Ind Pharm 29:1013–26
   PubMed Web of Science ®Google Scholar
• Järvinen K, Järvinen T, Urtti A. (1995). Ocular absorption following topical delivery. Adv Drug Deliv Rev 16:3–19
   Web of Science ®Google Scholar
• Kakkar S, Kaur IP. (2011). Spanlastics – a novel nanovesicular carrier system for ocular delivery. Int J Pharm 413:202–10
   PubMed Web of Science ®Google Scholar
• Kassem MA, Abdel Rahman AA, Ghorab MM, et al. (2007). Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs. Int J Pharm 340:126–33
   PubMed Web of Science ®Google Scholar
• Kaur IP, Garg A, Singla AK, Aggarwal D. (2004). Vesicular systems in ocular drug delivery: an overview. Int J Pharm 269:1–14
   PubMed Web of Science ®Google Scholar
• Kaur IP, Rana C, Singh M, et al. (2012). Development and evaluation of novel surfactant-based elastic vesicular system for ocular delivery of fluconazole. J Ocul Pharmacol Ther 28:484–96
   PubMed Web of Science ®Google Scholar
• Lee EH, Kim A, Oh YK, Kim CK. (2005). Effect of edge activators on the formation and transfection efficiency of ultradeformable liposomes. Biomaterials 26:205–10
   PubMed Web of Science ®Google Scholar
• Lee VH, Robinson JR. (1986). Topical ocular drug delivery: recent developments and future challenges. J Ocul Pharmacol 2:67–108
   PubMedGoogle Scholar
• Manosroi A, Khanrin P, Werner RG, et al. (2010). Entrapment enhancement of peptide drugs in niosomes. J Microencapsul 27:272–80
   PubMed Web of Science ®Google Scholar
• Monem AS, Ali FM, Ismail MW. (2000). Prolonged effect of liposomes encapsulating pilocarpine HCl in normal and glaucomatous rabbits. Int J Pharm 198:29–38
   PubMed Web of Science ®Google Scholar
• Muller RH, Mader K, Gohla S. (2000). Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. Eur J Pharm Biopharm 50:161–77
   PubMed Web of Science ®Google Scholar
• Ning M, Gu Z, Pan H, et al. (2005). Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antifungal drug clotrimazole. Indian J Exp Biol 43:150–7
   PubMedGoogle Scholar
• Prabagar B, Yoo BK, Woo JS, et al. (2007). Enhanced bioavailability of poorly water-soluble clotrimazole by inclusion with beta-cyclodextrin. Arch Pharm Res 30:249–54
   PubMed Web of Science ®Google Scholar
• Rosen MJ. (2004). Surfactants and interfacial phenomena. 3rd ed. Hoboken (NJ): Wiley-Interscience
   Google Scholar
• Sawyer PR, Brogden RN, Pinder RM, et al. (1975). Clotrimazole: a review of its antifungal activity and therapeutic efficacy. Drugs 9:424–47
   PubMed Web of Science ®Google Scholar
• Shen Y, Tu J. (2007). Preparation and ocular pharmacokinetics of ganciclovir liposomes. AAPS J 9:E371–7
   PubMed Web of Science ®Google Scholar
• Souto EB, Muller RH. (2006). Investigation of the factors influencing the incorporation of clotrimazole in SLN and NLC prepared by hot high-pressure homogenization. J Microencapsul 23:377–88
   PubMed Web of Science ®Google Scholar
• Tamilvanan S, Benita S. (2004). The potential of lipid emulsion for ocular delivery of lipophilic drugs. Eur J Pharm Biopharm 58:357–68
   PubMed Web of Science ®Google Scholar
• van den Bergh BA, Bouwstra JA, Junginger HE, Wertz PW. (1999). Elasticity of vesicles affects hairless mouse skin structure and permeability. J Control Release 62:367–79
   PubMed Web of Science ®Google Scholar
• van den Bergh BA, Wertz PW, Junginger HE, Bouwstra JA. (2001). Elasticity of vesicles assessed by electron spin resonance, electron microscopy and extrusion measurements. Int J Pharm 217:13–24
   PubMed Web of Science ®Google Scholar
• Wilson B, Samanta MK, Santhi K, et al. (2008). Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease. Brain Res 1200:159–68
   PubMed Web of Science ®Google Scholar
• Winnicka K, Sosnowska K, Wieczorek P, et al. (2011). Poly(amidoamine) dendrimers increase antifungal activity of Clotrimazole. Biol Pharm Bull 34:1129–33
   PubMed Web of Science ®Google Scholar
• Yoshioka T, Sternberg B, Florence AT. (1994). Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60 and 80) and a sorbitan triester (Span 85). Int J Pharm 105:1–6
   Web of Science ®Google Scholar
• Zimmer A, Kreuter J. (1995). Microspheres and nanoparticles used in ocular delivery systems. Adv Drug Deliv Rev 16:61–73
   Web of Science ®Google Scholar